Lubrizol will participate in World Health Expo (WHX) Dubai from February 9–12, 2026 (Booth #S13.B112), underscoring its focus on advancing medical device innovation through expanded global manufacturing capabilities. As part of this effort, Lubrizol is strengthening its footprint in India with new contract manufacturing capabilities, including a cutting-edge medical manufacturing facility in Chennai, Tamil Nadu, slated to become operational by mid-2026. The site will manufacture high-precision medical tubing for neurovascular and cardiovascular applications, such as balloon catheters and components used in minimally invasive procedures.
The Chennai facility will leverage Lubrizol’s expertise in medical-grade thermoplastic polyurethane (TPU) and other biocompatible engineered polymers. Capabilities will include single- and multi-lumen precision extrusion of TPU, Nylon, Pebax® and other thermoplastics, tri-layer and balloon tubing, as well as advanced braiding—supporting applications ranging from electrostimulation to cardiovascular and neurovascular therapies.
“Our investments in India reflect a long-term commitment to local manufacturing, R&D and technical excellence,” said Mittal Shah, Business Head, Lubrizol. “By expanding high-performance, biocompatible manufacturing capabilities, we are enabling customers to accelerate medical device development for India and global markets.” Visitors can meet Lubrizol experts at Booth #S13.B112 during WHX Dubai to explore design, development and manufacturing solutions for next-generation medical devices.
Lubrizol delivers specialty chemistry solutions that advance mobility, improve well-being and enhance everyday life. Through advanced polymers, collaborative design and contract manufacturing, the company supports customers from concept to commercialization with a focus on quality, compliance and performance. A Berkshire Hathaway company founded in 1928, Lubrizol operates more than 100 manufacturing, sales and technical facilities worldwide, with over 7,000 employees.
Lubrizol IMEA serves high-growth markets across India, the Middle East and Africa, supported by corporate offices, a global capabilities center and manufacturing sites in Maharashtra, Gujarat and Tamil Nadu. The region follows a strong local-for-local strategy, combining technical expertise with regional insights to drive innovation through targeted investments and partnerships.
